Esperion Therapeutics, Inc. (ESPR) — Analyst estimates
Consensus analyst estimates for Esperion Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 107.78M | 0.02 | 1 |
| 2027 | 130.9M | 0.09 | 1 |
| 2028 | 504.61M | 0.43 | 4 |
| 2029 | 658.8M | 0.51 | 2 |
| 2030 | 744.5M | 0.67 | 2 |
Consensus analyst estimates by fiscal year.